Asia Pacific Biopharma Excipients Market Research Report 2024-2030: Patent Expiry of Blockbuster Biologics such as Erbitux, Rituxan, Herceptin, Avastin, Aranesp, and Enbrel Fueling Investments
19. November 2024 11:28 ET
|
Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Asia Pacific Biopharma Excipients Market Size, Share and Trends Analysis Report by Product (Solubilizers & Surfactants/Emulsifiers, Polyols,...
Global Biosimilars and Follow-On Biologics Market Report 2024-2034 - Expanding the Portfolio of Biosimilars for Rare Diseases
31. Mai 2024 06:46 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Biosimilars and Follow-On Biologics Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Biosimilars and...
Unlocking the Potential: Investment in R&D Drives Oncology Biosimilars Growth 2023
21. September 2023 07:48 ET
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global oncology biosimilars market...
Biosimilars and Follow-On Biologics Market Report 2023: Regulatory Hurdles Slowing Down Access to Biosimilars
14. Juni 2023 04:33 ET
|
Research and Markets
Dublin, June 14, 2023 (GLOBE NEWSWIRE) -- The "Biosimilars and Follow-On Biologics Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.World revenue for the...
Biosimilars Global Market Report 2022: Production of Insulin Biosimilars Presents Opportunities
01. November 2022 09:33 ET
|
Research and Markets
Dublin, Nov. 01, 2022 (GLOBE NEWSWIRE) -- The "Biosimilars Global Market Report 2022: By Product, By Types, By Application" report has been added to ResearchAndMarkets.com's offering. The global...
$3.27 Billion Worldwide Oncology Biosimilars Industry to 2031 - Identify Growth Segments for Investment
22. März 2022 05:33 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2022: By Drug, By Cancer, By Distribution" report has been added to ResearchAndMarkets.com's offering. This...
Worldwide Biosimilar Industry to 2027 - Featuring Novartis, Pfizer and Teva Among Others
22. Februar 2022 08:28 ET
|
Research and Markets
Dublin, Feb. 22, 2022 (GLOBE NEWSWIRE) -- The "Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's...
Global Top Selling Biologics Report 2021-2030: Monoclonal Antibody, Hormone, Enzyme, Fusion Protein, Interferon, Gene Therapy
04. August 2021 04:08 ET
|
Research and Markets
Dublin, Aug. 04, 2021 (GLOBE NEWSWIRE) -- The "Top Selling Biologics Market, 2021-2030: Focus on Product Landscape Assessment, Ongoing Clinical Trials, Promotional Content Analysis, Other Life Cycle...
Insights on the Biosimilars Global Market to 2025 - Featuring Amgen, Cipla and Pfizer Among Others
15. Juni 2021 06:18 ET
|
Research and Markets
Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global biosimilars market should reach $60.1...
Outlook on the Biosimilar Global Market to 2026 - by Segment, Manufacturer Type, Indication and Region
02. Juni 2021 06:18 ET
|
Research and Markets
Dublin, June 02, 2021 (GLOBE NEWSWIRE) -- The "Biosimilar Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's...